25 results
POS AM
LSB
LakeShore Biopharma Co., Ltd
23 Jan 24
Prospectus update (post-effective amendment)
4:18pm
Group’s marketed product and product candidates may become subject to unfavorable pricing regulations, third-party reimbursement practices … of this product, maintain compliance with ongoing regulatory requirement, properly price and obtain coverage and adequate reimbursement of this product
424B3
b18p r490zv
15 Aug 23
Prospectus supplement
8:00am
POS AM
dvfqmp ad17oe5
8 Aug 23
Prospectus update (post-effective amendment)
4:06pm
20-F
b9xn1q ia
26 Jul 23
Annual report (foreign)
4:02pm
424B3
xowyqy5b9q83
5 Jun 23
Prospectus supplement
4:03pm
F-1/A
i92neit1eysqxa0zg1z
12 May 23
Registration statement (foreign) (amended)
4:05pm
F-1
6dgo15 vfpzyt9b4gwy
12 Apr 23
Registration statement (foreign)
8:49am
F-4
EX-10.10
uzenjkn
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
EX-10.5
av8cbjcwbyko0vw
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
yo34swet
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
EX-10.9
2mxwp5b
28 Dec 22
Registration of securities (foreign)
6:58am
DRS/A
2mvg94w69rtej34i6u
7 Dec 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.9
irdu2i07uzdkemp007dl
14 Nov 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.10
1qc98wo7s2c
14 Nov 22
Draft registration statement (amended)
12:00am
DRS/A
xfxebz
14 Nov 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.5
qivzi
14 Nov 22
Draft registration statement (amended)
12:00am